Trial Profile
Clinical Trials Insight: 700039827
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Dec 2008
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- Sponsors Sanofi Genzyme
- 15 Dec 2008 New trial record.